Drug Pipeline

Drug Pipeline Market Research Reports

1 . Drug Pipeline Market Research Reports Analysis and Trends

Discovering and bringing new drugs to mainstream commercial market typically takes an average of 10-15 years of research and clinical development efforts. Drug developers need to make sure safe and effective drug available for patient in quick time. The first step is to target the protein available in the patient’s body that is associated with microorganism causing a disease, through tracking of cellular network of proteins an appropriate target for a drug is selected. Through a series of trials, right drug candidate got chosen.
 
According to “NOVARTIS”, bringing a new drug in market takes 14 years of research and cost around USD 2 billion, 10K+ clinical trials out of these, one leads to successful drug development.
Title Published Pages Price
Malignant Mesothelioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 600 USD 2,500.00
Pulmonary Arterial Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 370 USD 2,500.00
Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 67 USD 3,500.00
Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 581 USD 2,500.00
Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 (GABA(A) Receptor Subunit Alpha 5 or GABRA5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 50 USD 3,500.00
Arterial Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 40 USD 2,000.00
Actinic (Solar) Keratosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 68 USD 2,000.00
Achondroplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 61 USD 2,000.00
Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 39 USD 3,500.00
Premature Labor (Tocolysis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 84 USD 2,000.00
Opium (Opioid) Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 163 USD 2,000.00
Rhinovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 83 USD 2,000.00
Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 36 USD 3,500.00
Chemotherapy Induced Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 166 USD 2,000.00
Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 207 USD 2,000.00
Influenzavirus B Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 176 USD 2,000.00
Somatostatin Receptor Type 4 (SSTR4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 36 USD 3,500.00
Auto Inflammatory Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 39 USD 2,000.00
Choroidal Neovascularization Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 67 USD 2,000.00
Synaptosomal Associated Protein 25 (Synaptosomal Associated 25 kDa Protein or Super Protein or SNAP25) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 51 USD 2,500.00
Paraganglioma (Glomus Jugulare Tumor) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 42 USD 2,000.00
Turner Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 35 USD 2,000.00
Hantavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 40 USD 2,000.00
Acute Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 45 USD 2,000.00
NADPH Oxidase (NOX or EC 1.6.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 68 USD 2,500.00
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 292 USD 2,500.00
Generalized Anxiety Disorder (GAD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 48 USD 2,000.00
Charcot-Marie-Tooth Disease Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 43 USD 2,000.00
Malignant Neoplasms Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 52 USD 2,000.00
High-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 117 USD 2,000.00
Glutamate Ionotropic Receptor NMDA Type Subunit (NMDAR or GRIN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 143 USD 3,500.00
Cells Expressing Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 37 USD 2,500.00
Amino Acid Metabolism Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 107 USD 2,000.00
Pancreatic Islet Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 41 USD 2,000.00
Serine-Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 41 USD 2,500.00
Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin Component or F9 or EC 3.4.21.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 63 USD 2,500.00
Transforming Growth Factor (TGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 184 USD 3,500.00
Schwannoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 35 USD 2,000.00
Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 41 USD 2,000.00
Articular Cartilage Defect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 36 USD 2,000.00
B Cell Lymphoma 2 (Bcl 2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 99 USD 2,500.00
Integrin Beta 5 (ITGB5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 35 USD 2,500.00
Sirtuin (SIRT or EC 2.3.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 69 USD 2,500.00
Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamylase or OTC or EC 2.1.3.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 41 USD 2,500.00
Mycobacterium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 298 USD 2,500.00
Lipodystrophy (Lipoatrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 40 USD 2,000.00
Xerostomia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 39 USD 2,000.00
Caspase 1 (Interleukin 1 Beta Convertase or Interleukin 1 Beta Converting Enzyme or p45 or CASP1 or EC 3.4.22.36) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 39 USD 2,500.00
Cells Expressing Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 40 USD 2,500.00
Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 67 USD 2,500.00

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected